AXSM — AXSOME THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.26% (2024 Q3)
Avg. % of fund
0.11%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 2,263 +176 +8.4% 0.11% $275K $121.45
2025 Q2 REDUCED 2,087 -80 -3.7% 0.11% $218K $104.39
2025 Q1 REDUCED 2,167 -2,989 -58.0% 0.12% $253K $116.63
2024 Q3 ADDED 5,156 +4,985 +2915.2% 0.26% $463K $89.87
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AXSM price (monthly, adj. close)

Other funds also holding AXSM

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 59.3% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 4.96% Tri Locum Partners LP 3Y 4.78% PFM Health Sciences, LP 3Y 7Y 4.58% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.52% First Turn Management, LLC 4.32% Deep Track Capital, LP 3Y 3.74% SUPERSTRING CAPITAL MANAGEMENT LP 3.66% Rhenman & Partners Asset Management AB 3Y 7Y 1.96% Privium Fund Management B.V. 3Y 1.91%
← Back to EntryPoint Capital, LLC Holdings